Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Metabolism: Clinical and Experimental|October 31, 2024
The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservationKonstantinos Stefanakis, Michail Kokkorakis, Christos S MantzorosMetabolism: Clinical and Experimental|July 27, 2020
The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver diseaseNikolaos Perakakis, Konstantinos Stefanakis, Christos S MantzorosDiabetes, Obesity & Metabolism|January 15, 2025
Apolipoprotein CIII correlates with lipoproteins in the fed state and is not regulated by leptin administration in states of hypoleptinemia induced by acute or chronic energy deficiency: Results from two randomised controlled trialsArantxa Ramirez-Cisneros, Konstantinos Stefanakis, Christos S MantzorosClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 9, 2025
Novel Machine-learning Models Outperform Noninvasive Tests in Metabolic Dysfunction-associated Steatohepatitis With fibrosisKonstantinos Stefanakis, Geltrude Mingrone, Jacob George, et al.Metabolism: Clinical and Experimental|November 20, 2024
Accurate non-invasive detection of MASH with fibrosis F2-F3 using a lightweight machine learning model with minimal clinical and metabolomic variablesKonstantinos Stefanakis, Geltrude Mingrone, Jacob George, et al.Metabolism: Clinical and Experimental|January 9, 2026
Proteomic effects of short-term liraglutide vs. placebo in a blinded crossover RCT: Implications for efficacy, safety, and comparison with semaglutideKonstantinos Stefanakis, Valeria Gutierrez de Piñeres, Preethi Veeragandham, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 31, 2021
Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non-alcoholic steatohepatitisNikolaos Perakakis, Konstantinos Stefanakis, Michael Feigh, et al.Metabolism: Clinical and Experimental|August 3, 2024
Longitudinal proteomics of leptin treatment in humans with acute and chronic energy deficiency-induced hypoleptinemia reveal novel, mainly immune-related, pleiotropic effectsKonstantinos Stefanakis, Martina Samiotaki, Vassiliki Papaevangelou, et al.Metabolism: Clinical and Experimental|October 31, 2024
Leptin physiology and pathophysiology in energy homeostasis, immune function, neuroendocrine regulation and bone healthKonstantinos Stefanakis, Jagriti Upadhyay, Arantxa Ramirez-Cisneros, et al.Nature Communications|June 18, 2024
Total and H-specific GDF-15 levels increase in caloric deprivation independently of leptin in humansPavlina Chrysafi, Laura Valenzuela-Vallejo, Konstantinos Stefanakis, et al.Pageof 3